ARKAF
Get informed when a big investor buys or sells
+ FollowUndervalued by 14.9% based on the discounted cash flow analysis.
| Market cap | $5.19 Billion |
|---|---|
| Enterprise Value | $8.55 Billion |
| Dividend Yield | $4.18 (6.20%) |
| Earnings per Share | $0.83 |
| Beta | 0.95 |
| Outstanding Shares | 75,655,533 |
| P/E Ratio | 252.61 |
|---|---|
| PEG | -570.49 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 0.9 |
| Enterprise Value to Revenue | 0.96 |
| Enterprise Value to EBIT | 29.07 |
| Enterprise Value to Net Income | 206 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.82 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Arkema SA engages in manufacturing and supply of chemical products. It operates through followings segments: High Performance Materials, Industrials Specialties and Coating Solutions. The High Performance Materials segment includes the T...